Thomas Skripu

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy—Review of the Literature and Future Outlook

R. Gutzmer, I. Satzger, N. Möhn, 2019, Journal of clinical medicine.